Quantifying microcalcification activity in the thoracic aorta
Alexander J Fletcher, Maria Lembo, Jacek Kwiecinski, Maaz B J Syed, Jennifer Nash, Evangelos Tzolos, Rong Bing, Sebastien Cadet, Gillian MacNaught, Edwin J R van Beek, Alistair J Moss, Mhairi K Doris, Niki L Walker, Damini Dey, Philip D Adamson, David E Newby, Piotr J Slomka, Marc R Dweck, Alexander J Fletcher, Maria Lembo, Jacek Kwiecinski, Maaz B J Syed, Jennifer Nash, Evangelos Tzolos, Rong Bing, Sebastien Cadet, Gillian MacNaught, Edwin J R van Beek, Alistair J Moss, Mhairi K Doris, Niki L Walker, Damini Dey, Philip D Adamson, David E Newby, Piotr J Slomka, Marc R Dweck
Abstract
Background: Standard methods for quantifying positron emission tomography (PET) uptake in the aorta are time consuming and may not reflect overall vessel activity. We describe aortic microcalcification activity (AMA), a novel method for quantifying 18F-sodium fluoride (18F-NaF) uptake in the thoracic aorta.
Methods: Twenty patients underwent two hybrid 18F-NaF PET and computed tomography (CT) scans of the thoracic aorta less than three weeks apart. AMA, as well as maximum (TBRmax) and mean (TBRmean) tissue to background ratios, were calculated by two trained operators. Intra-observer repeatability, inter-observer repeatability and scan-rescan reproducibility were assessed. Each 18F-NaF quantification method was compared to validated cardiovascular risk scores.
Results: Aortic microcalcification activity demonstrated excellent intra-observer (intraclass correlation coefficient 0.98) and inter-observer (intraclass correlation coefficient 0.97) repeatability with very good scan-rescan reproducibility (intraclass correlation coefficient 0.86) which were similar to previously described TBRmean and TBRmax methods. AMA analysis was much quicker to perform than standard TBR assessment (3.4min versus 15.1min, P<0.0001). AMA was correlated with Framingham stroke risk scores and Framingham risk score for hard cononary heart disease.
Conclusions: AMA is a simple, rapid and reproducible method of quantifying global 18F-NaF uptake across the ascending aorta and aortic arch that correlates with cardiovascular risk scores.
Keywords: Image analysis; Modalities; Molecular imaging agents; Others; PET; Technical; Tests; Tracers.
Conflict of interest statement
The authors have no relevant conflicts of interest to declare.
© 2021. The Author(s).
Figures
References
- Desai MY, Cremer PC, Schoenhagen P. Thoracic aortic calcification: Diagnostic, prognostic, and management considerations. JACC Cardiovasc Imaging. 2018;11:1012–1026. doi: 10.1016/j.jcmg.2018.03.023.
- Kim J, Budoff MJ, Nasir K, Wong ND, Yeboah J, Al-Mallah MH, Shea S, Dardari ZA, Blumenthal RS, Blaha MJ, Cainzos-Achirica M. Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis. 2017;257:1–8. doi: 10.1016/j.atherosclerosis.2016.12.012.
- Cho IJ, Chang HJ, Cho I, Heo R, Lee SE, Shim CY, Hong GR, Chung N. Association of thoracic aorta calcium score with exercise blood pressure response and clinical outcomes in elderly individuals: Differential impact of aorta calcification compared with coronary artery calcification. J Am Heart Assoc. 2016;5:e003131. doi: 10.1161/JAHA.115.003131.
- Tison GH, Guo M, Blaha MJ, McClelland RL, Allison MA, Szklo M, Wong ND, Blumenthal RS, Budoff MJ, Nasir K. Multisite extracoronary calcification indicates increased risk of coronary heart disease and all-cause mortality: The Multi-Ethnic Study of Atherosclerosis. J Cardiovasc Comput Tomogr. 2015;9:406–414. doi: 10.1016/j.jcct.2015.03.012.
- Criqui MH, Denenberg JO, Ix JH, McClelland RL, Wassel CL, Rifkin DE, Carr JJ, Budoff MJ, Allison MA. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA. 2014;311:271–278. doi: 10.1001/jama.2013.282535.
- Hutcheson JD, Maldonado N, Aikawa E. Small entities with large impact: Microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol. 2014;25:327–332. doi: 10.1097/MOL.0000000000000105.
- Derlin T, Richter U, Bannas P, Begemann P, Buchert R, Mester J, Klutmann S. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med. 2010;51:862–865. doi: 10.2967/jnumed.110.076471.
- Irkle A, Vesey AT, Lewis DY, Skepper JN, Bird JL, Dweck MR, Joshi FR, Gallagher FA, Warburton EA, Bennett MR, Brindle KM, Newby DE, Rudd JH, Davenport AP. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun. 2015;6:7495. doi: 10.1038/ncomms8495.
- Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, Richardson H, White A, McKillop G, van Beek EJ, Boon NA, Rudd JH, Newby DE. Coronary arterial 18F-sodium fluoride uptake: A novel marker of plaque biology. J Am Coll Cardiol. 2012;59:1539–1548. doi: 10.1016/j.jacc.2011.12.037.
- Kwiecinski J, Tzolos E, Adamson PD, Cadet S, Moss AJ, Joshi N, Williams MC, van Beek EJR, Dey D, Berman DS, Newby DE, Slomka PJ, Dweck MR. Coronary 18F-sodium fluoride predicts outcome in patients with coronary artery disease. J Am Coll Cardiol. 2020;75:3061–3074. doi: 10.1016/j.jacc.2020.04.046.
- Blomberg BA, de Jong PA, Thomassen A, Lam MGE, Vach W, Olsen MH, Mali WPTM, Narula J, Alavi A, Høilund-Carlsen PF. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: Results of the CAMONA study. Eur J Nucl Med Mol Imaging. 2017;44:249–258. doi: 10.1007/s00259-016-3552-9.
- Blomberg BA, Thomassen A, de Jong PA, Simonsen JA, Lam MG, Nielsen AL, Mickley H, Mali WP, Alavi A, Høilund-Carlsen PF. Impact of personal characteristics and technical factors on quantification of sodium 18F-fluoride uptake in human arteries: Prospective evaluation of healthy subjects. J Nucl Med. 2015;56:1534–1540. doi: 10.2967/jnumed.115.159798.
- Joshi NV, Toor I, Shah AS, Carruthers K, Vesey AT, Alam SR, Sills A, Hoo TY, Melville AJ, Langlands SP, Jenkins WS, Uren NG, Mills NL, Fletcher AM, van Beek EJ, Rudd JH, Fox KA, Dweck MR, Newby DE. Systemic atherosclerotic inflammation following acute myocardial infarction: Myocardial infarction begets myocardial infarction. J Am Heart Assoc. 2015;4:e001956. doi: 10.1161/JAHA.115.001956.
- Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22:312–318. doi: 10.1161/01.STR.22.3.312.
- D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40–43. doi: 10.1161/01.STR.25.1.40.
- Moss AJ, Doris MK, Andrews JPM, Bing R, Daghem M, van Beek EJR, Forsyth L, Shah ASV, Williams MC, Sellers S, Leipsic J, Dweck MR, Parker RA, Newby DE, Adamson PD. Molecular coronary plaque imaging using 18F-fluoride. Circ Cardiovasc Imaging. 2019;12:e008574. doi: 10.1161/CIRCIMAGING.118.008574.
- Moss AJ, Dweck MR, Doris MK, Andrews JPM, Bing R, Forsythe RO, Cartlidge TR, Pawade TA, Daghem M, Raftis JB, Williams MC, van Beek EJR, Forsyth L, Lewis SC, Lee RJ, Shah ASV, Mills NL, Newby DE, Adamson PD. Ticagrelor to reduce myocardial injury in patients with high-risk coronary artery plaque. JACC Cardiovasc Imaging. 2020;13:1549–1560. doi: 10.1016/j.jcmg.2019.05.023.
- Lassen ML, Kwiecinski J, Dey D, Cadet S, Germano G, Berman DS, Adamson PD, Moss AJ, Dweck MR, Newby DE, Slomka PJ. Triple-gated motion and blood pool clearance corrections improve reproducibility of coronary. Eur J Nucl Med Mol Imaging. 2019;46:2610–2620. doi: 10.1007/s00259-019-04437-x.
- Doris MK, Otaki Y, Krishnan SK, Kwiecinski J, Rubeaux M, Alessio A, Pan T, Cadet S, Dey D, Dweck MR, Newby DE, Berman DS, Slomka PJ. Optimization of reconstruction and quantification of motion-corrected coronary PET-CT. J Nucl Cardiol. 2020;27:494–504. doi: 10.1007/s12350-018-1317-5.
- Kwiecinski J, Berman DS, Lee SE, Dey D, Cadet S, Lassen ML, Germano G, Jansen MA, Dweck MR, Newby DE, Chang HJ, Yun M, Slomka PJ. Three-hour delayed imaging improves assessment of coronary. J Nucl Med. 2019;60:530–535. doi: 10.2967/jnumed.118.217885.
- Massera D, Doris MK, Cadet S, Kwiecinski J, Pawade TA, Peeters FECM, Dey D, Newby DE, Dweck MR, Slomka PJ. Analytical quantification of aortic valve 18F-sodium fluoride PET uptake. J Nucl Cardiol. 2018;27(3):962–972. doi: 10.1007/s12350-018-01542-6.
- Tzolos E, Kwiecinski J, Lassen ML, Cadet S, Adamson PD, Moss AJ, Joshi N, Williams MC, van Beek EJR, Dey D, Berman DS, Dweck MR, Newby DE and Slomka PJ. Observer repeatability and interscan reproducibility of 18F-sodium fluoride coronary microcalcification activity. J Nucl Cardiol 2020.
- Kwiecinski J, Cadet S, Daghem M, Lassen ML, Dey D, Dweck MR, Berman DS, Newby DE, Slomka PJ. Whole-vessel coronary 18F-sodium fluoride PET for assessment of the global coronary microcalcification burden. Eur J Nucl Med Mol Imaging. 2020;47:1736–1745. doi: 10.1007/s00259-019-04667-z.
- Dweck MR, Khaw HJ, Sng GK, Luo EL, Baird A, Williams MC, Makiello P, Mirsadraee S, Joshi NV, van Beek EJ, Boon NA, Rudd JH, Newby DE. Aortic stenosis, atherosclerosis, and skeletal bone: is there a common link with calcification and inflammation? Eur Heart J. 2013;34:1567–1574. doi: 10.1093/eurheartj/eht034.
- Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A, Investigators d-P Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011;378:1547–1559. doi: 10.1016/S0140-6736(11)61383-4.
- Dufouil C, Beiser A, McLure LA, Wolf PA, Tzourio C, Howard VJ, Westwood AJ, Himali JJ, Sullivan L, Aparicio HJ, Kelly-Hayes M, Ritchie K, Kase CS, Pikula A, Romero JR, D’Agostino RB, Samieri C, Vasan RS, Chêne G, Howard G, Seshadri S. Revised framingham stroke risk profile to reflect temporal trends. Circulation. 2017;135:1145–1159. doi: 10.1161/CIRCULATIONAHA.115.021275.
- Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Tomaselli GF, Guidelines ACoCAHATFoP ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;2014(129):S49–S73.
- Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. doi: 10.1161/01.CIR.97.18.1837.
- Vaz S, Falkmer T, Passmore AE, Parsons R, Andreou P. The case for using the repeatability coefficient when calculating test-retest reliability. PLoS ONE. 2013;8:e73990. doi: 10.1371/journal.pone.0073990.
Source: PubMed